Clicky

Kiromic BioPharma, Inc.(KRBP)

Description: Kiromic BioPharma, Inc. operates as a biotechnology company. The Company focuses on target discovery and gene editing through artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma serves customers in the United States.


Keywords: Biotechnology Artificial Intelligence Neural Network

Home Page: www.kiromic.com

KRBP Technical Analysis

7707 Fannin
Houston, TX 77054
United States
Phone: 832 968 4888


Officers

Name Title
Mr. Pietro Bersani CPA, J.D. CEO & Director
Dr. Scott Dahlbeck M.D., Pharm.D., PharmD Chief of Staff
Mr. Daniel Clark Chief Financial Officer
Dr. Leonardo Mirandola Ph.D. Chief Scientific Officer
Dr. Michael Ryan Ph.D. Chief Bioinformatics Research Computing Officer

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 15.106
Price-to-Sales TTM: 0
IPO Date: 2020-10-16
Fiscal Year End: December
Full Time Employees: 60
Back to stocks